New Anticancer Drugs Interfere with DNA Binding Properties of EBV

By LabMedica International staff writers
Posted on 18 Mar 2019

Image: A simplified diagram of the structure of Epstein-Barr virus (EBV) (Photo courtesy of Wikimedia Commons).

The recent synthesis of small molecular drugs that interfere with the DNA binding properties of Epstein-Barr virus (EBV) suggests that it may be possible to develop medications for the treatment of EBV-associated cancers.

Persistent latent infection with EBV has been linked to development of various cancer types, including Burkitt’s lymphoma, nasopharyngeal carcinoma (NPC), and Hodgkin’s lymphoma. The only viral protein that is consistently expressed in these tumors is Epstein-Barr nuclear antigen 1 (EBNA1), a multifunctional DNA binding protein critical for viral replication, genome maintenance, viral gene expression, and host cell survival. Since EBNA1 is the only viral protein consistently expressed in all EBV-associated tumors, it is an attractive target for therapeutic intervention.

To this end, investigators at the Wistar Institute (Philadelphia, PA, USA) used a fragment-based approach and x-ray crystallography to identify a 2,3-disubstituted benzoic acid series that selectively inhibited the DNA binding activity of EBNA1. They characterized these inhibitors biochemically and in cell-based assays, including chromatin immunoprecipitation and DNA replication assays.

The investigators reported in the March 6, 2019, online edition of the journal Science Translational Medicine that EBNA1 inhibitors demonstrated potent tumor growth suppressor activity in several EBV-dependent xenograft models, including patient-derived xenografts for NPC. These inhibitors selectively blocked EBV gene transcription and altered the cellular transforming growth factor-beta (TGF-beta) signaling pathway in NPC tumor xenografts.

Overall, the EBNA1-specific inhibitors showed favorable pharmacological properties and have the potential to be further developed for the treatment of EBV-associated cancers.

“EBNA1 is found in all EBV-associated tumors and does not look like any other protein in the human body,” said senior author Dr. Paul M. Lieberman, professor, of chemical biology and translational medicine at the Wistar Institute. “These characteristics, along with the protein’s particular structure, make EBNA1 a very attractive therapeutic target.”

Related Links:
Wistar Institute

Latest BioResearch News

Channels

Clinical Chemistry

view channel

Image: The Vertex 70 Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) spectrophotometer (Photo courtesy of the University of Guelph).

Molecular Diagnostics

view channel

Image: A multisegment injection-non-aqueous-capillary electrophoresis–mass spectrometer (MSI-NACE-MS) (Photo courtesy of McMaster University)

An Analytical Method to Monitor Dietary Fat Intake

An advanced analytical technique was used to determine unequivocally the composition of fats in the diets of pregnant women and female patients suspected of being deficient in certain dietary fats.... Read more

Germline Risk Variants Found in Prostate Cancer Patients

Studies done over the past five years or so have unearthed pathogenic germline variants in some 12% to 17% of men with prostate cancer, and such alterations can impact everything from the treatment options... Read more

Non-Invasive Blood Assay Can Detect Early Colorectal Cancer

Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). In general, colon cancer begins... Read more

New Blood Test Can Determine When an Individual Was Exposed to a Pathogenic Microorganism

An international research team has developed a diagnostic blood test – initially for the recurring form of vivax malaria – that can determine when an individual was exposed to a pathogenic microorganism,... Read more

Hematology

view channel

Image: The UniCel DxI 800 Access Immunoassay System (Photo courtesy of Beckman Coulter).

Soluble Transferrin Receptor Investigated in Iron Deficiency Anemia

Anemia is a global public health problem and approximately 30% of the world's population suffered from anemia, with children and pregnant women being the most affected. Microcytic hypochromic anemia is... Read more

Image: A blood smear from a patient with microcytosis which may predict underlying cancer even in the presence of normal hemoglobin. Microcytic red blood cells measure 6 μm or less in diameter. The mean corpuscular volume is generally less than 80 fL (Photo courtesy of Sara Beth Fazio, MD).

Microcytosis Is a Risk Marker of Cancer in Primary Care

Microcytosis is a term used to describe red blood cells that are smaller than normal. Anemia is when there are low numbers of properly functioning red blood cells in the body. In microcytic anemia, the... Read more

Image: The CS-2400 is a high performance coagulation station that allows laboratories to perform routine and specialized testing including platelet function tests (Photo courtesy of Sysmex).

Lupus Anticoagulant Prolongs Activated Partial-Thromboplastin Time in COVID-19

Patients with coronavirus disease 2019 (COVID-19) have a profound hypercoagulable state, and complicating venous thrombotic events are common. Abnormalities in coagulation screening measures, including... Read more

Image: The ACL Top 550 hemostasis analyzer (Photo courtesy of Werfen).

Blood Clotting Causes Significant Mortality in COVID-19 Patients

Although the underlying pulmonary pathophysiology remains incompletely understood, severe COVID-19 infection is associated with a marked alveolar inflammatory cell infiltrate, together with a systemic... Read more

Immunology

view channel

Image: CTL- Immunospot Analyzers come in a wide range of models, each of which is designed to make assay analysis faster, easier, and more accurate than ever before (Photo courtesy of Cellular Technology Limited).

Initial Immune Response After Dengue Virus Infection Identified

Dengue virus (DENV) is a member of the clinically-relevant Flavivirus genus together with Zika virus, yellow fever virus and others. With four distinct serotypes, DENV is thought to infect between 280... Read more

Immune Microenvironment Changes Contribute to Early-Stage Multiple Myeloma

Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Plasma cells help you fight infections by making antibodies that recognize and attack germs. Multiple myeloma... Read more

Image: The Simultest IMK-Lymphocyte is a two-color direct immunoﬂuorescence reagent kit for enumerating percentages of the following mature human leucocyte subsets in erythrocyte-lysed whole blood (Photo courtesy of BDBiosciences).

Immune Responses Evaluated for Tick-Borne Encephalitis

Tick-borne encephalitis (TBE) is an important vector-borne infection of the central nervous system (CNS). The majority of all reported cases of TBE occur in adults. However, TBE should also be included... Read more

Image: Linking peptide specificities with T cell transcriptomes (Photo courtesy of University of California, Santa Cruz).

High-Throughput T Cell Profiling Technique Developed

T cells recognize foreign or aberrant antigens presented by major histocompatibility complex (MHC-I) expressing cells through the T cell receptor (TCR) and is the first critical step towards establishment... Read more

Microbiology

view channel

Different Methods Compared for Species Identification of Enterococcus

Biochemical test‐based methodologies are still used in some laboratories for the identification of bacterial isolates, mainly because of the need for the performance of drug susceptibility tests.... Read more

Image: Salmonella are gram-negative, rod-shaped, facultative anaerobic bacteria. Newly developed sensitive and specific assays are able to detect different serotypes of Salmonella, paving the way for rapid serotyping directly from specimens (Photo courtesy of Public Health Image Library, [U.S.] Centers for Disease Control and Prevention)

A Series of Sensitive and Specific DNA-Based Assays Detects and Differentiates Salmonella Serotypes

A team of Australian researchers developed a series of sensitive and specific assays to detect and identify different serotypes (serovars) of Salmonella, a common cause of bacterial foodborne disease worldwide.... Read more

Giemsa Stain Outperforms Urease Test for Helicobacter Pylori Diagnosis

More than 50% of the worldwide population is infected by Helicobacter pylori which is harbored in their upper gastrointestinal tract. Despite having chronic gastritis, most people infected by H.... Read more

Image: The Oxford Nanopore MinION device (Photo courtesy of Oxford Nanopore Technologies).

Deep Throat SARS-CoV-2 Viral Load Ascertained in Saliva Samples

Posterior oropharyngeal saliva samples are a non-invasive specimen more acceptable to patients and health-care workers. Unlike severe acute respiratory syndrome, patients with COVID-19 had the highest... Read more

Pathology

view channel

Image: Schematic diagram of how the representative tumor sampling method lessens bias in molecular analyses (Photo courtesy of Francis Crick Institute).

Representative Tumor Sampling Method Lessens Molecular Analyses Bias

Over the past decade, clinical scientists have demonstrated the inability of an individual biopsy or formalin-fixed paraffin-embedded (FFPE) block to capture the genetic diversity of a solid tumor.... Read more

$Image: Schematic diagram of circulating tumor DNA (ctDNA) which is found in serum and plasma fractions from blood. The mechanism of ctDNA release is unknown, though apoptosis, necrosis, and active secretion from tumor cells have been hypothesized. Once ctDNA is isolated, it can be sequenced for mutational analysis (Photo courtesy of Rachel June Wong).$